Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer

Fig. 3

lollipop plots showing the location of mutations in each gene. The grey bar represents the whole length of the protein, and the colored boxes are functional domains of each protein. The height of vertical lines represents a total number of mutations identified in each amino acid. A to E, mutations detected in KRAS, BRAF, PIK3CA, APC and TP53, respectively

Back to article page